Regression of Sight-Threatening Macular Edema in Type 2 Diabetes Following Treatment With the Anti–Tumor Necrosis Factor Monoclonal Antibody Infliximab-Reference-Cited by-同舟云学术

Regression of Sight-Threatening Macular Edema in Type 2 Diabetes Following Treatment With the Anti–Tumor Necrosis Factor Monoclonal Antibody Infliximab

Published:2005-02-01 Issue:2 Volume:28 Page:445-447
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Sfikakis Petros P.¹,Markomichelakis Nikos²,Theodossiadis George P.³,Grigoropoulos Vlassis³,Katsilambros Nikos¹,Theodossiadis Panayiotis G.⁴

Affiliation:

1. First Department of Propedeutic Medicine, Laikon Hospital, Athens University Medical School, Athens, Greece

2. Ocular Inflammation and Immunology Service, Gennimatas Hospital, Athens, Greece

3. Department of Ophthalmology, Dynan Hospital, Athens, Greece

4. Department of Ophthalmology, Athens University Medical School, Athens, Greece

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/28/2/445/665894/zdc00205000445.pdf

Reference16 articles.

1. Ciulla TA, Amador AG, Zinman B: Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care 26:2653–2664, 2003

2. Antcliff RJ, Marshall J: The pathogenesis of edema in diabetic maculopathy. Semin Ophthalmol 14:223–232, 1999

3. Limb GA, Webster L, Soomro H, Janikoun S, Shilling J: Platelet expression of tumour necrosis factor-alpha (TNF-alpha), TNF receptors and intercellular adhesion molecule-1 (ICAM-1) in patients with proliferative diabetic retinopathy. Clin Exp Immunol 118:213–218, 1999

4. Limb GA, Hollifield RD, Webster L, Charteris DG, Chignell AH: Soluble TNF receptors in vitreoretinal proliferative disease. Invest Ophthalmol Vis Sci 42:1586–1591, 2001

5. Romeo G, Liu WH, Asnaghi V, Kern TS, Lorenzi M: Activation of nuclear factor-κB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 51:2241–2248, 2002

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated aqueous TNF‐α levels are associated with more severe functional and anatomic findings in eyes with diabetic macular oedema;Clinical & Experimental Ophthalmology;2024-07-28

2. Interleukin-17A in diabetic retinopathy: The crosstalk of inflammation and angiogenesis;Biochemical Pharmacology;2024-07

3. Cell and molecular targeted therapies for diabetic retinopathy;Frontiers in Endocrinology;2024-06-14

4. The role of microglia in the development of diabetic retinopathy;npj Metabolic Health and Disease;2024-06-03

5. Treatments for diabetic retinopathy and diabetic macular edema in pipeline;Therapeutic Targets for Diabetic Retinopathy;2024